Muutke küpsiste eelistusi

Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 3rd edition [Kõva köide]

Edited by (Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center)
  • Formaat: Hardback, 848 pages, kõrgus x laius: 276x216 mm
  • Ilmumisaeg: 01-Oct-2025
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0443273561
  • ISBN-13: 9780443273568
Teised raamatud teemal:
  • Kõva köide
  • Hind: 276,84 €
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 2-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 848 pages, kõrgus x laius: 276x216 mm
  • Ilmumisaeg: 01-Oct-2025
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0443273561
  • ISBN-13: 9780443273568
Teised raamatud teemal:
Handbook of Brain Tumor Chemotherapy, Molecular Therapies, and Immunotherapy, Third Edition offers a unique cutting-edge collection of basic science and clinical information brain tumor chemotherapy research. This book represents the most complete single-volume resource available for information on the subject of brain tumor chemotherapy. Including a multidisciplinary approach, this volume combines recent advances tumor therapy with molecular biology, molecular therapeutics, immunobiology, and immunotherapy approaches in one location. Chapters new to this volume include cutting-edge research on the molecular underpinnings of brain tumors such as glioblastoma and other gliomas and the targeted molecular therapies to consider for treatment.
Section 1: PHARMACOLOGICAL AND CLINICAL APPLICATIONS
Section 2: INNOVATIVE CHEMOTHERAPY DELIVERY
Section 3: MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS
Section 4: CHEMOTHERAPY SPECIFIC TUMORS ADULTS
Section 5: CHEMOTHERAPY SPECIFIC TUMORS PEDIATRICS
Section 6: IMMUNOTHERAPY FOR BRAIN TUMORS
Section 7: RESPONSE ASSESSMENT, QUALITY OF LIFE, NEUROPSYCHOLOGY, AND NEW
FRONTIERS
Herbert B. Newton, M.D., FAAN, is currently the Medical Director for the Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center, in Cleveland, Ohio, where he is also a Professor of Neurology and Solid Tumor Oncology, and holds the William Burton Risman Neurological Institute Chair in Memory and Cognition. Prior to that he was the Director of the Neuro-Oncology Center and Medical Neuro-Oncology Program at the Advent Health Cancer Institute and Advent Health Orlando Campus in Orlando, Florida. He is also retired as a Professor of Neurology and Neurosurgery, Dardinger Neuro-Oncology Center, Esther Dardinger Endowed Chair in Neuro-Oncology and Division of Neuro-Oncology at the Ohio State University Medical Center and James Cancer Hospital, in Columbus, Ohio. He is a Diplomate of the American Board of Psychiatry and Neurology, a Fellow of the American Academy of Neurology and Royal Society of Medicine, and a member of numerous national and international societies.